Lamotrigine Extended-Release
NDC 10370-207, lamotrigine, tablet, film coated, extended release, from Par Health USA, LLC.
- Product NDC
- 10370-207
- Status
- Listed
- Labeler
- Par Health USA, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA201374
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10370-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMOTRIGINE100 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10370-207-11 | 10370020711 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (10370-207-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d5ec4d58-c669-4ab4-ba62-b71007536854NADAC price for package 10370020711
GET /v1/drugs/nadac/10370020711
Use it
Look up 10370-207 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10370-207 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10370-207. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.